Showing results (11-20 of 602) with videos related to
Sort By:
Pageof 61
Cancer Research|May 3, 2008
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)Marina Konopleva, Julie Watt, Rooha Contractor, et al.Cytotherapy|March 17, 2010
Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatmentShannon Kidd, Lisa Caldwell, Martin Dietrich, et al.Cancer Research|March 5, 2009
Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolismIsmael Samudio, Michael Fiegl, Michael AndreeffHaematologica|June 30, 2017
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemiaZhihong Zeng, Wenbin Liu, Twee Tsao, et al.Molecular Carcinogenesis|December 19, 2007
1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell linesJun Hong, Ismael Samudio, Sudhakar Chintharlapalli, et al.Endocrinology|May 15, 2003
Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cellsShaheen Khan, Maen Abdelrahim, Ismael Samudio, et al.Expert Review of Proteomics|January 19, 2018
Cell-surface proteomics for the identification of novel therapeutic targets in cancerLaura Kuhlmann, Emma Cummins, Ismael Samudio, et al.Molecular Carcinogenesis|June 30, 2004
Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathwaysChunhua Qin, Ismael Samudio, Sharon Ngwenya, et al.The Journal of Biological Chemistry|August 25, 2005
2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancerIsmael Samudio, Marina Konopleva, Numsen Hail, et al.Expert Review of Clinical Pharmacology|November 18, 2021
Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerationsMaria Siddiqui, Marina KonoplevaPageof 61